Closed-loop System for Oxygen Delivery and Exercise in Chronic Obstructive Pulmonary Disease (FreeO2-rehab)
Primary Purpose
COPD, Oxygen Therapy, Hypercapnia
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Automated settings on the oxygen delivery device
Manual settings with FreeO2 system in collection mode
Sponsored by
About this trial
This is an interventional treatment trial for COPD
Eligibility Criteria
Inclusion Criteria:
- 40 Years and older
- Patient with COPD severe to very severe requiring long-term Oxygen Therapy
- Hypercapnia (PaCO2 > 45mmHg)
- Former or current smoker greater than or equal to 10 pack-years
Exclusion Criteria:
- Pregnant or breast-feed woman
- Patients under guardianship
- Imprisoned patients
Sites / Locations
- Hopital Universitaire
- Centre ATRIR
- Centre Henri BAZIRE
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Fixed oxygen flow delivery
FreeO2 system
Arm Description
Oxygen flow delivery is adjusted by respiratory therapists. Standard medical treatment.
FreeO2 is a new system that automatically adjusts the oxygen flow delivered to patients in a closed-loop based on the SpO2 signal. This system is intended to maintain SpO2 in a predefined target and to adapt oxygen flow to patient's needs.
Outcomes
Primary Outcome Measures
Change in Endurance time
Duration during the endurance shuttle walking test
Secondary Outcome Measures
Change in Dyspnea during ESWT
Visual analogic scores of dyspnea during the endurance shuttle walking test
Change in Muscle fatigue during ESWT
Visual analogic scores of leg discomfort during the endurance shuttle walking test
Change in Respiratory frequency during ESWT
Respiratory frequency measurement by the FreeO2 system during the endurance shuttle walking test
Change in PaCO2 during ESWT
EtCO2 measurement by the FreeO2 system during the endurance shuttle walking test
Hypercapnia level at baseline
Blood gases at rest
Change in Cardiac frequency during ESWT
Cardiac frequency measurement by the FreeO2 system during the endurance shuttle walking test
Change in SpO2 during ESWT
Pulse oxygen saturation during the endurance shuttle walking test
Full Information
NCT ID
NCT01575327
First Posted
March 13, 2012
Last Updated
March 13, 2018
Sponsor
AGIR à Dom
Collaborators
University Hospital, Grenoble
1. Study Identification
Unique Protocol Identification Number
NCT01575327
Brief Title
Closed-loop System for Oxygen Delivery and Exercise in Chronic Obstructive Pulmonary Disease
Acronym
FreeO2-rehab
Official Title
Using a Closed-loop System for Oxygen Delivery (FreeO2) to Optimize Exercise Tolerance During Walk in Patients With COPD, Oxygen Therapy and Hypercapnia
Study Type
Interventional
2. Study Status
Record Verification Date
January 2017
Overall Recruitment Status
Completed
Study Start Date
July 2012 (undefined)
Primary Completion Date
June 2016 (Actual)
Study Completion Date
June 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
AGIR à Dom
Collaborators
University Hospital, Grenoble
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to investigate the benefit of Closed-loop System for Oxygen Delivery (FreeO2) as compared with fixed oxygen flow during endurance shuttle walking test in patients with Chronic obstructive pulmonary disease (COPD), oxygen therapy and hypercapnia.
The study was designed to test the following hypotheses:
As compared with fixed oxygen flow, the FreeO2 Oxygen Delivery system leads to higher exercise tolerance (distance during ESWT) and lower desaturation events without increase in hypercapnia in patients with COPD, oxygen therapy and hypercapnia.
As compared with fixed oxygen flow, the FreeO2 Oxygen Delivery system leads to lower dyspnea and leg fatigue scores at a given endurance time during the shuttle walking test in patients with COPD, oxygen therapy and hypercapnia.
As compared with fixed oxygen flow, the FreeO2 Oxygen Delivery system leads to lower cardiac and respiratory frequencies at a given endurance time during the shuttle walking test in patients with COPD, oxygen therapy and hypercapnia.
Detailed Description
Background:
In spite of oxygen therapy, desaturations frequently occur during exercise in COPD patients. Although current recommendations are to add 1 L/min to the baseline oxygen flow during exertion, a new closed-loop system (FreeO2) automatically and continuously adjusts the oxygen flow to the patient's needs based on the oxygen saturation by pulse oximetry (SpO2), end-tidal CO2 (EtCO2) and respiratory rate. A preliminary study showed significant improvement in exercise tolerance in COPD patients not needing oxygen therapy. Although oxygen flow could be two fold increased during exercise, a worsening hypercapnia is plausible in severe COPD.
Aim of this study is to evaluate this system during endurance shuttle walking test in COPD patients with oxygen therapy and hypercapnia.
Methods: The investigators proposed to conduct a controlled, randomized cross-over study comparing the efficacy of a Closed-loop System for Oxygen Delivery (FreeO2) as compared with fixed oxygen flow during an endurance shuttle walking test in patients with COPD, oxygen therapy and hypercapnia.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COPD, Oxygen Therapy, Hypercapnia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Fixed oxygen flow delivery
Arm Type
Active Comparator
Arm Description
Oxygen flow delivery is adjusted by respiratory therapists. Standard medical treatment.
Arm Title
FreeO2 system
Arm Type
Experimental
Arm Description
FreeO2 is a new system that automatically adjusts the oxygen flow delivered to patients in a closed-loop based on the SpO2 signal. This system is intended to maintain SpO2 in a predefined target and to adapt oxygen flow to patient's needs.
Intervention Type
Device
Intervention Name(s)
Automated settings on the oxygen delivery device
Intervention Description
FreeO2 automatically adjusts the oxygen flow delivered to patients based on the SpO2 signal and collects the cardiorespiratory parameters
Intervention Type
Device
Intervention Name(s)
Manual settings with FreeO2 system in collection mode
Intervention Description
FreeO2 system does not adjust oxygen flow but collects the cardiorespiratory parameters
Primary Outcome Measure Information:
Title
Change in Endurance time
Description
Duration during the endurance shuttle walking test
Time Frame
Day 0 (inclusion) + 14 and D0 +21
Secondary Outcome Measure Information:
Title
Change in Dyspnea during ESWT
Description
Visual analogic scores of dyspnea during the endurance shuttle walking test
Time Frame
Day 0 (inclusion) + 14 and D0 +21
Title
Change in Muscle fatigue during ESWT
Description
Visual analogic scores of leg discomfort during the endurance shuttle walking test
Time Frame
Day 0 (inclusion) + 14 and D0 +21
Title
Change in Respiratory frequency during ESWT
Description
Respiratory frequency measurement by the FreeO2 system during the endurance shuttle walking test
Time Frame
Day 0 (inclusion) + 14 and D0 +21
Title
Change in PaCO2 during ESWT
Description
EtCO2 measurement by the FreeO2 system during the endurance shuttle walking test
Time Frame
Day 0 (inclusion) + 14 and D0 +21
Title
Hypercapnia level at baseline
Description
Blood gases at rest
Time Frame
Day 0 (inclusion) - baseline evaluation
Title
Change in Cardiac frequency during ESWT
Description
Cardiac frequency measurement by the FreeO2 system during the endurance shuttle walking test
Time Frame
Day 0 (inclusion) + 14 and D0 +21
Title
Change in SpO2 during ESWT
Description
Pulse oxygen saturation during the endurance shuttle walking test
Time Frame
Day 0 (inclusion) + 14 and D0 +21
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
40 Years and older
Patient with COPD severe to very severe requiring long-term Oxygen Therapy
Hypercapnia (PaCO2 > 45mmHg)
Former or current smoker greater than or equal to 10 pack-years
Exclusion Criteria:
Pregnant or breast-feed woman
Patients under guardianship
Imprisoned patients
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean-Louis Pepin, MD, PhD
Organizational Affiliation
Laboratoire EFCR, CHU de Grenoble, 38043, Grenoble, France
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hopital Universitaire
City
Grenoble
Country
France
Facility Name
Centre ATRIR
City
Nyons
ZIP/Postal Code
26110
Country
France
Facility Name
Centre Henri BAZIRE
City
Saint-Julien-de-Raz
ZIP/Postal Code
38134
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
30166425
Citation
Vivodtzev I, L'Her E, Vottero G, Yankoff C, Tamisier R, Maltais F, Lellouche F, Pepin JL. Automated O2 titration improves exercise capacity in patients with hypercapnic chronic obstructive pulmonary disease: a randomised controlled cross-over trial. Thorax. 2019 Mar;74(3):298-301. doi: 10.1136/thoraxjnl-2018-211967. Epub 2018 Aug 30.
Results Reference
derived
Learn more about this trial
Closed-loop System for Oxygen Delivery and Exercise in Chronic Obstructive Pulmonary Disease
We'll reach out to this number within 24 hrs